| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/06/2002 | WO2002044210A2 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain |
| 06/06/2002 | WO2002044209A2 Cytonkine receptor zcytor19 |
| 06/06/2002 | WO2002044208A1 Methods of screening for agonists and antagonists of the hneaa81 receptor |
| 06/06/2002 | WO2002044203A2 Production of recombinant bmp-2 |
| 06/06/2002 | WO2002044199A2 Neurotoxins with enhanced target specificity |
| 06/06/2002 | WO2002043661A2 Recombinant anti-cd30 antibodies and uses thereof |
| 06/06/2002 | WO2002043660A2 Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment |
| 06/06/2002 | WO2002043651A2 Methods of utilizing cultured non-gvhd inducing t lymphocytes to treat disease |
| 06/06/2002 | WO2002043478A2 Transgenic transchromosomal rodents for making human antibodies |
| 06/06/2002 | WO2002016440A3 Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of haemophilus influenzae infections |
| 06/06/2002 | WO2002014860A8 Functional protein arrays |
| 06/06/2002 | WO2002013606A3 Improved insecticidal bacteria, and methods for making and using them |
| 06/06/2002 | WO2002005843A3 Human rrp sequences and methods of use |
| 06/06/2002 | WO2001096557A3 A human homologue of the dbf4/ask1 protein, nucleic acids, and methods related to the same |
| 06/06/2002 | WO2001094414A3 THE HUMAN VOLTAGE GATED SODIUM CHANNEL β-1A SUBUNIT AND METHODS OF USE |
| 06/06/2002 | WO2001090389A3 Production of silk-like proteins in plants |
| 06/06/2002 | WO2001090360A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/06/2002 | WO2001090334A3 Drug metabolizing enzymes |
| 06/06/2002 | WO2001064884A3 G12l, a gene associated with the thermal response |
| 06/06/2002 | WO2001048209B1 Genes identified as required for proliferation of e. coli |
| 06/06/2002 | WO2001036645A3 Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same |
| 06/06/2002 | WO2000024782A3 Modified peptides, comprising an fc domain, as therapeutic agents |
| 06/06/2002 | WO2000022430A3 Neisseria genomic sequences and methods of their use |
| 06/06/2002 | US20020069424 Protein-protein interactions in neurodegenerative disorders |
| 06/06/2002 | US20020069423 Prion-free transgenic ungulates |
| 06/06/2002 | US20020069422 Proteins for use in the treatment of trypanosome infection, cancer, inflammation and immunological defects |
| 06/06/2002 | US20020068825 Polypeptide for use in the treatment of nervous system disorders |
| 06/06/2002 | US20020068824 Membrane protein for use in the treatnment of diabetes, hypotension, endocrine defects |
| 06/06/2002 | US20020068716 Pituitary-tumor-transforming-gene (PTTG) polypeptide expressed by pituitary tumor cells, which binds anti-PTTG antibody. |
| 06/06/2002 | US20020068694 Glycosylated VEGF-B and method for increasing the amount of soluble VEGF-B |
| 06/06/2002 | US20020068353 Nucleotide sequence coding tumor polypeptide for use as anticarcinogeneic agents |
| 06/06/2002 | US20020068346 Enzymatic polypeptide for use in the prevention and treatment of viral diseases |
| 06/06/2002 | US20020068330 Composition for use in the propagation of bacteria |
| 06/06/2002 | US20020068329 Fusion proteins for prodrug activation |
| 06/06/2002 | US20020068328 Liposomal pharmaceutical conjugate for use inthe treatment and diagnosis of tumors; antitumor agents; anticarcinogeneic agents |
| 06/06/2002 | US20020068325 Methods and compositions for highly efficient production of heterologous proteins in yeast |
| 06/06/2002 | US20020068323 Nucleotide sequences which code polypeptide for use in human therapeutics ad diagnostics |
| 06/06/2002 | US20020068319 32 human secreted proteins |
| 06/06/2002 | US20020068289 Screening library for preferential clones; obtain sample from library, insert into expression vector, transform cell, monitor cells for preferential gene expression, detect expression of preferential fuson protein |
| 06/06/2002 | US20020068286 Detecting modulators of gene associated with weight control; obtain cells incubate with modulator, measure expression of preferential genes, compare to control |
| 06/06/2002 | US20020068276 Methods for selecting functional polypeptides |
| 06/06/2002 | US20020068070 High molecular weight major outer membrane protein of moraxella |
| 06/06/2002 | US20020068063 Regulating protein activity with an ubiquitin pathway protein binding moiety coupled to a targeting moiety; used to perform target ubiquitination |
| 06/06/2002 | US20020068062 Inhibitors of the formation of soluble human CD23 |
| 06/06/2002 | US20020068061 Antibody inhibits heparanase activity; prevent angiogenesis, cell proliferation, tumor cell proliferation, invasion of circulating tumor cells, metastases, inflammation and autoimmune conditions |
| 06/06/2002 | US20020068056 Monoclonal antibodies (mabs) against tumor-associated antigens, the preparation and use thereof |
| 06/06/2002 | EP1144454A3 Modified peptides as therapeutic agents |
| 06/06/2002 | DE10058596A1 Verfahren zum Screening von chemischen Verbindungen zur Modulierung der Wechselwirkung einer EVH1-Domäne oder eines Proteins mit einer EVH1-Domäne mit einer EVH1-Bindedomäne oder einem Protein mit einer EVH1-Bindedomäne sowie ein Verfahren zum Nachweis besagter Wechselwirkung Method for screening chemical compounds for modulating the interaction of an EVH1 domain or a protein having an EVH1 domain with an EVH1-binding domain or a protein having an EVH1-binding domain and a method for the detection of said interaction |
| 06/06/2002 | CA2791831A1 Rna interference mediating small rna molecules |
| 06/06/2002 | CA2604066A1 Compositions and methods for diagnosing or treating psoriasis |
| 06/06/2002 | CA2436941A1 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain |
| 06/06/2002 | CA2433665A1 Projection against mycobacterial infections |
| 06/06/2002 | CA2430559A1 Method of making a protein polymer and uses of the polymer |
| 06/06/2002 | CA2430485A1 Cytonkine receptor zcytor19 |
| 06/06/2002 | CA2430473A1 Diagnosis and treatment of disease |
| 06/06/2002 | CA2430365A1 Neurotoxins with enhanced target specificity |
| 06/06/2002 | CA2430351A1 Human protooncogene and protein encoded therein |
| 06/06/2002 | CA2430331A1 Human cervical cancer 2 protooncogene and protein encoded therein |
| 06/06/2002 | CA2430257A1 Transforming growth factor-beta-related molecules and uses thereof |
| 06/06/2002 | CA2430084A1 Obp1:a protein selectively expressed in osteoblasts |
| 06/06/2002 | CA2430082A1 Retina-specific human proteins c70rf9, c120rf7, mpp4 and f379 |
| 06/06/2002 | CA2430039A1 Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment |
| 06/06/2002 | CA2429814A1 Rna interference mediating small rna molecules |
| 06/06/2002 | CA2429599A1 Use of b7rp1 antagonists in ige-mediated disorders |
| 06/06/2002 | CA2428595A1 Staphylococcus aureus protein staau_r2, gene encoding it and uses thereof |
| 06/06/2002 | CA2425872A1 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof |
| 06/05/2002 | EP1211315A1 Recombinant vectors for producing HCV envelope proteins |
| 06/05/2002 | EP1211310A1 Novel yeast variants and process for producing glycoprotein containing mammalian type sugar chain |
| 06/05/2002 | EP1210463A2 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications |
| 06/05/2002 | EP1210462A2 Polymorphisms in the human hpxr gene and their use in diagnostic and therapeutic applications |
| 06/05/2002 | EP1210455A1 Novel glycosyl sulfotransferases gst-4 alpha, gst-4 beta, and gst-6 |
| 06/05/2002 | EP1210449A1 Methods for the detection, analysis and isolation of nascent proteins |
| 06/05/2002 | EP1210444A2 Isoforms of snare molecules and the uses thereof in modulation of cellular exocytosis |
| 06/05/2002 | EP1210438A2 Ehrlichia canis genes and vaccines |
| 06/05/2002 | EP1210435A1 Fhm, A NOVEL MEMBER OF THE TNF LIGAND SUPERGENE FAMILY |
| 06/05/2002 | EP1210426A2 Polymorphisms in a klotho gene |
| 06/05/2002 | EP1210424A1 Novel b7-4 molecules and uses therefor |
| 06/05/2002 | EP1210423A1 Novel abc transporter and uses thereof |
| 06/05/2002 | EP1210422A2 Human abc2 transporter and uses thereof |
| 06/05/2002 | EP1210421A1 Methods for diagnosis and treatment of human diseases including hypertension |
| 06/05/2002 | EP1210419A2 Human transmembrane proteins |
| 06/05/2002 | EP1210412A1 Pichia methanolica glyceraldehyde-3-phosphate dehydrogenase 2 promoter and terminator |
| 06/05/2002 | EP1210411A1 Compositions and methods for improved cell culture |
| 06/05/2002 | EP1210374A1 Human monoclonal antibodies to prostate specific membrane antigen |
| 06/05/2002 | EP1210372A2 Human monoclonal antibodies to her2/neu |
| 06/05/2002 | EP1210370A1 Human tumor necrosis factor receptor tr16 |
| 06/05/2002 | EP1210366A1 Homologs of a pneumococcal protein and fragments for vaccines |
| 06/05/2002 | EP1210111A1 Gamma-herpesvirus dna and methods of use |
| 06/05/2002 | EP1037658B1 Ifnar/ifn complex |
| 06/05/2002 | EP0746398B1 Antibody purification |
| 06/05/2002 | EP0736095B1 Human circulating cytokine cc-1 |
| 06/05/2002 | EP0724637B2 Corticotropin-releasing factor 2 receptors |
| 06/05/2002 | EP0656419B1 Method for highly purifying human serum albumin |
| 06/05/2002 | CN1352691A Human complement C3-degrading polypeptide from i(streptococcus pneumoniae) |
| 06/05/2002 | CN1352687A A variant of c6 beta-chemokine leukotactin-1 (shLKn-1) with enhanced biological activity |
| 06/05/2002 | CN1352686A Cytokine receptor chain |
| 06/05/2002 | CN1352685A Monomcyte-derived nucleic acids and rolated compositions and methods |
| 06/05/2002 | CN1352683A Compositions and methods for the treatment and diagnosis of breast cancer |
| 06/05/2002 | CN1352681A Enzymatic reductions with dihydrogen via metal catalyzed cofactor regeneration |
| 06/05/2002 | CN1352651A Method for inhibiting macrophage infiltration using monoconal anti-alpha-D-antibodies |